FealtySign in

Cigna Group

(CI)

CIK 1739940 · SEC filings only

Not gradedDividend record
shown as history
company entity
24 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

24 declarations · 5 raised · 14 held · 0 cut · held 19 quarters

  1. HELD$1.5600/shperiod ended 2026-06-30Filing ↗
  2. RAISED$1.5600/shperiod ended 2026-03-31Filing ↗
  3. HELD$1.5100/shperiod ended 2025-09-30Filing ↗
  4. HELD$1.5100/shperiod ended 2025-06-30Filing ↗
  5. RAISED$1.5100/shperiod ended 2025-03-31Filing ↗
  6. HELD$1.4000/shperiod ended 2024-09-30Filing ↗
  7. HELD$1.4000/shperiod ended 2024-06-30Filing ↗
  8. RAISED$1.4000/shperiod ended 2024-03-31Filing ↗
  9. HELD$1.2300/shperiod ended 2023-12-31Filing ↗
  10. HELD$1.2300/shperiod ended 2023-09-30Filing ↗
  11. HELD$1.2300/shperiod ended 2023-06-30Filing ↗
  12. RAISED$1.2300/shperiod ended 2023-03-31Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedBuyback record
harness minimum not met
company entity
0 resolved promises

Not enough resolved promises to grade

0 of the 4 resolved buyback promises needed to publish a reliability grade. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

buyback history

Free scorecards show the 12 most recent resolved buyback promises. See the complete multi-year record with Pro.

See Pro →

Open promises (1)

Open · buyback authorization

bringing the company's total share repurchase authority to $10.3 billion

resolves in ~138 days$10.30Breceipt →
0 resolved buyback promises · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →
Not yet gradedGuidance record
harness minimum not met
company entity
0 resolved promises

Not enough GAAP-comparable guidance to grade

0 of the 4 resolved guidance promises needed to publish a reliability grade. Much of this company’s guidance is non-GAAP, which has no comparable GAAP actual in SEC XBRL to check it against — shown below, never scored. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

guidance history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro →

Guidance shown, not graded (38)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance fy · Jul 30, 2026
    The Cigna Group’s outlook for full year 2026 consolidated adjusted income from operations 1,2 is at least $30.45 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. eps guidance fy · Apr 30, 2026
    The Cigna Group’s outlook for full year 2026 consolidated adjusted income from operations 1,2 is at least $30.35 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  3. revenue guidance fy · Feb 5, 2026
    The Cigna Group’s outlook 2 for full year 2026 adjusted revenues 2,3 is approximately $280.0 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  4. eps guidance fy · Feb 5, 2026
    The Cigna Group’s outlook for full year 2026 consolidated adjusted income from operations 1,2 is at least $7.950 billion, or at least $30.25 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  5. eps guidance fy · Oct 30, 2025
    The Cigna Group’s outlook 2 for full year 2025 consolidated adjusted income from operations 1,2 is at least $29.60 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  6. eps guidance fy · Jul 31, 2025
    The Cigna Group’s outlook 2 for full year 2025 consolidated adjusted income from operations 1,2 is at least $29.60 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  7. eps guidance fy · Jan 30, 2025
    at least $29.50
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  8. revenue guidance fy · Jan 30, 2025
    at least $252,000
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  9. revenue guidance fy · Aug 1, 2024
    The Cigna Group's outlook 2 for full year 2024 adjusted revenues 2,3 is at least $235.0 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  10. eps guidance fy · Aug 1, 2024
    The Cigna Group’s outlook 2 for full year 2024 consolidated adjusted income from operations 1,2 is at least $8.065 billion, or at least $28.40 per share 2 .
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  11. revenue guidance fy · May 2, 2024
    The Cigna Group's outlook 2 for full year 2024 adjusted revenues 2,3 is at least $235.0 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  12. eps guidance fy · May 2, 2024
    The Cigna Group’s outlook 2 for full year 2024 consolidated adjusted income from operations 1,2 is at least $8.065 billion, or at least $28.40 per share 2 .
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  13. revenue guidance fy · Nov 2, 2023
    The Cigna Group's outlook 2 for full year 2023 adjusted revenues 2,5 increased to at least $192.0 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  14. eps guidance fy · Nov 2, 2023
    The Cigna Group’s outlook 2 for full year 2023 consolidated adjusted income from operations 1,2 is at least $7.36 billion, or at least $24.75 per share 2 .
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  15. eps guidance fy · Aug 3, 2023
    The Cigna Group’s outlook 2 for full year 2023 consolidated adjusted income from operations 1,2 is at least $7.36 billion , or at least $24.70 per share
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  16. revenue guidance fy · Aug 3, 2023
    The Cigna Group's outlook 2 for full year 2023 adjusted revenues 2,5 increased to at least $190.0 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  17. revenue guidance fy · May 5, 2023
    The Cigna Group's outlook 2 for full year 2023 adjusted revenues 2,5 increased to at least $188.0 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  18. eps guidance fy · May 5, 2023
    The Cigna Group’s outlook 2 for full year 2023 consolidated adjusted income from operations 1,2 increased to at least $7.36 billion , or at least $24.70 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  19. revenue guidance fy · Feb 3, 2023
    Cigna's outlook 2,13 for full year 2023 adjusted revenues 2,5 is projected to be at least $187.0 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  20. eps guidance fy · Feb 3, 2023
    Cigna’s outlook 2,13 for full year 2023 consolidated adjusted income from operations 1,2 is projected to be at least $7.33 billion , or at least $24.60 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  21. revenue guidance fy · Nov 3, 2022
    Cigna's outlook for full year 2022 adjusted revenues 2,3 is projected to be at least $179 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  22. eps guidance fy · Nov 3, 2022
    Cigna’s outlook for full year 2022 consolidated adjusted income from operations 1,2 is projected to be at least $7.23 billion , or at least $23.10 per share 2
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  23. revenue guidance fy · Aug 4, 2022
    Cigna's outlook for full year 2022 adjusted revenues 1,3 is projected to be at least $178 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  24. eps guidance fy · Aug 4, 2022
    Cigna’s outlook for full year 2022 consolidated adjusted income from operations 2,3 is projected to be at least $7.165 billion , or at least $22.90 per share 3
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  25. eps guidance fy · Feb 3, 2022
    Cigna’s outlook for full year 2022 consolidated adjusted income from operations 2,3 is projected to be at least $6.95 billion , or at least $22.40 per share 3
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  26. revenue guidance fy · Feb 3, 2022
    Cigna's outlook for full year 2022 adjusted revenues 1,3 is projected to be at least $177 billion
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  27. eps guidance fy · Nov 4, 2021
    Cigna’s outlook for full year 2021 consolidated adjusted income from operations 2,3 is at least $6.96 billion, or at least $20.35 per share.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  28. revenue guidance fy · Nov 4, 2021
    Cigna's outlook for full year 2021 adjusted revenues 1,3 is projected to be at least $172 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  29. revenue guidance fy · Aug 5, 2021
    Cigna's outlook for full year 2021 adjusted revenues 1,3 is projected to be at least $170 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  30. eps guidance fy · Aug 5, 2021
    Cigna’s outlook for full year 2021 consolidated adjusted income from operations 2,3 is at least $6.96 billion, or at least $20.20 per share.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  31. eps guidance fy · May 7, 2021
    Cigna’s outlook for full year 2021 consolidated adjusted income from operations 2,3 is at least $7.0 billion, or at least $20.20 per share.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  32. revenue guidance fy · May 7, 2021
    Cigna's outlook for full year 2021 adjusted revenues 1,3 is projected to be at least $166 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  33. eps guidance fy · Feb 4, 2021
    Adjusted income from operations 2,3 is projected to be at least $6.95 billion in 2021, or at least $20.00 per share 3
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  34. revenue guidance fy · Feb 4, 2021
    Adjusted revenues 1,3 are projected to be at least $165 billion in 2021
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  35. eps guidance fy · Nov 5, 2020
    Cigna’s outlook for full year 2020 consolidated adjusted income from operations 2,3 on a per share basis is in the range of $18.30 to $18.60 per share.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  36. revenue guidance fy · Nov 5, 2020
    Cigna's outlook for full year 2020 adjusted revenues 1,3 is approximately $158 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  37. revenue guidance fy · Jul 30, 2020
    Cigna's outlook for full year 2020 adjusted revenues 1,3 is $154 billion to $156 billion.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  38. eps guidance fy · Jul 30, 2020
    Cigna’s outlook for full year 2020 consolidated adjusted income from operations 2,3 on a per share basis is in the range of $18.00 to $18.60 per share.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
0 resolved guidance promises · 38dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →